Johns Hopkins Study of Psilocybin in Cancer Patients

Written By Josh Dunford

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Read Source: US National Library of Medicine

Josh Dunford
Previous

MDMA-Assisted Psychotherapy for PTSD
Next

LSD-Assisted Psychotherapy for Anxiety Related to Life-Threatening Illness